Endura Therapeutics Inc.
South San Francisco, CA
- UEI
- WWELGH5XSB38
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 329 Oyster Point Blvd, South San Francisco, CA 94080, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: multiplexed high throughput discovery of functional RNA-targeting small molecules via next-generation… | National Science Foundation | $303,445 |
Quick answers
What is Endura Therapeutics Inc.'s UEI?
Endura Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is WWELGH5XSB38.
Where is Endura Therapeutics Inc. located?
Endura Therapeutics Inc.'s physical address in SAM.gov is 329 Oyster Point Blvd, South San Francisco, CA 94080, USA.
Is Endura Therapeutics Inc. registered in SAM.gov?
Yes. Endura Therapeutics Inc.'s SAM.gov registration is active through May 12, 2027.
What is Endura Therapeutics Inc.'s most recent federal award?
Endura Therapeutics Inc.'s most recent federal grant award is Sbir phase i: multiplexed high throughput discovery of functional RNA-targeting small molecules via next-generation… (2507762), from National Science Foundation, on May 15, 2025.
On GovTribe
See Endura Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors